Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis

Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis

Background and aims: Hepatic steatosis of nonalcoholic etiology (nonalcoholic fatty liver disease; NAFLD) is an emergent condition that may lead to hepatic cirrhosis and finally to liver cancer. We evaluate the risk of developing hepatocellular carcinoma (HCC) and quantify the prognosis in terms of...

Full description

Bibliographic Details
Main Authors:	Fausto Petrelli, Michele Manara, Silvia Colombo, Gabriella De Santi, Michele Ghidini, Marco Mariani, Alessandro Iaculli, Emanuele Rausa, Valentina Rampulla, Marcella Arru, Matteo Viti, Veronica Lonati, Antonio Ghidini, Andrea Luciani, Antonio Facciorusso
Format:	Article
Language:	English
Published:	Elsevier 2022-08-01
Series:	Neoplasia: An International Journal for Oncology Research
Subjects:	Nonalcoholic fatty liver disease Steatosis NASH Hepatocellular carcinoma Meta-analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S1476558622000367

Similar Items

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
by: Jennifer Gallacher, et al.
Published: (2018-06-01)

Triglyceride-Glucose Index for Early Prediction of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of 121,975 Individuals
by: Azizullah Beran, et al.
Published: (2022-05-01)

Technical Acoustic Measurements Combined with Clinical Parameters for the Differential Diagnosis of Nonalcoholic Steatohepatitis
by: Yanan Zhao, et al.
Published: (2023-04-01)

Prevalence and Clinical Characteristics of Nonalcoholic Liver Disease in Type 2 Diabetes Mellitus Patients: A Crosssectional Study
by: Lakshmi Ravansamudram Hariharan, et al.
Published: (2021-04-01)

Enhancing Hepatic MBOAT7 Expression in Mice With Nonalcoholic Steatohepatitis
by: Martin C. Sharpe, et al.
Published: (2023-01-01)

Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis
by: Rasha AlShaalan, et al.
Published: (2015-01-01)

Impact of Diabetes Mellitus and Insulin on Nonalcoholic Fatty Liver Disease in the Morbidly Obese
by: Claudia B.M. Strey, et al.
Published: (2018-07-01)

Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Cyrielle Caussy, et al.
Published: (2020-10-01)

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
by: Umair Iqbal, et al.
Published: (2019-03-01)

Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
by: Gang Xu, et al.
Published: (2021-04-01)

Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients
by: Haghpanah Babak, et al.
Published: (2003-10-01)

Prediction of course and progression of nonalcoholic fatty liver disease in patients with obesity and pathology of the biliary tract with the help of mathematical modeling.
by: A. Yu. Filippova, et al.
Published: (2017-12-01)

Nonalcoholic fatty liver disease in asymptomatic obese women(a)(a)The work was originated in the Biomedical Research Unit of The Mexican Social Security Institute at Durango, Mex.
by: Heriberto Rodriguez-Hernandez, et al.
Published: (2010-04-01)

Liver Biopsy Hydroxyproline Content Is a Diagnostic for Hepatocellular Carcinoma in Murine Models of Nonalcoholic Steatohepatitis
by: Tyler L. Bissoondial, et al.
Published: (2020-10-01)

Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease
by: Gigliola Alberti, et al.
Published: (2020-11-01)

Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
by: Wasitha P. D. W. Thilakarathna, et al.
Published: (2024-02-01)

5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease
by: Marcin Banaszczak, et al.
Published: (2020-02-01)

The long‐term protective effects of neonatal administration of curcumin against nonalcoholic steatohepatitis in high‐fructose‐fed adolescent rats
by: Kasimu G. Ibrahim, et al.
Published: (2019-03-01)

Detection of patatin-like phospholipase domain-containing protein 3 in nonalcoholic fatty liver disease among egyptian patients
by: Kadry M El Saeed, et al.
Published: (2019-01-01)

Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity
by: Joseph L. Jilek, et al.
Published: (2021-12-01)

Celiac Disease, Gluten-Free Diet, and Metabolic and Liver Disorders
by: Marco Valvano, et al.
Published: (2020-03-01)

The genetics of nonalcoholic fatty liver disease
by: Christoph H. Österreicher;, et al.
Published: (2007-04-01)

A simple method for inducing nonalcoholic steatohepatitis with fibrosis
by: Leyla Yahaghi, et al.
Published: (2019-12-01)

Angiogenic effects of leptin in patients with nonalcoholic steatohepatitis
by: Gaafar Nagah, et al.
Published: (2005-01-01)

Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome
by: Martha D. Gay, et al.
Published: (2022-02-01)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
by: Sang Bong Ahn
Published: (2023-02-01)

Effects of L-Carnitine and N-Acetylcysteine on nonalcoholic hepatic steatosis in rats
by: Cemal Nas, et al.
Published: (2019-06-01)

The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease
by: Mary Barbara, et al.
Published: (2021-09-01)

Role of Chitinase 3-Like 1 Protein in the Pathogenesis of Hepatic Insulin Resistance in Nonalcoholic Fatty Liver Disease
by: Songhua Zhang, et al.
Published: (2021-01-01)

A Comparison of <sup>13</sup>C-Methacetin and <sup>13</sup>C-Octanoate Breath Test for the Evaluation of Nonalcoholic Steatohepatitis
by: Carmen Fierbinteanu-Braticevici, et al.
Published: (2023-03-01)

Nonalcoholic fatty liver disease in severely obese individuals: The influence of bariatric surgery
by: Antônio Ricardo de Andrade, et al.
Published: (2008-10-01)

Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review
by: Karima Begriche, et al.
Published: (2023-01-01)

Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2021-07-01)

Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
by: Juan Pablo Arab, et al.
Published: (2020-11-01)

Dietary Sodium and Nonalcoholic Fatty Liver Disease: A Systematic Review
by: Guilherme da Silva Ferreira, et al.
Published: (2023-02-01)

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
by: Jinwang Li, et al.
Published: (2021-12-01)

The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
by: Ivana Mikolasevic, et al.
Published: (2022-02-01)

Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease
by: Lucija Virović Jukić, et al.
Published: (2021-01-01)

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
by: A. V. Bogolyubova, et al.
Published: (2019-12-01)

Association of Hepatic Steatosis Index with Nonalcoholic Fatty Liver Disease Diagnosed by Non-Enhanced CT in a Screening Population
by: Jieun Chung, et al.
Published: (2021-11-01)